Switch to:
More From Other Websites
Johnson & Johnson to buy private drug developer for $1.75 billion Sep 30 2014
Johnson & Johnson to buy private drug developer for $1.75 billion Sep 30 2014
Johnson & Johnson buying Alios for $1.75B Sep 30 2014
Inovio/GeneOne Life Science Collaborate for Ebola Vaccine Sep 25 2014
Today's Market Thorns, Roses, and All Time Highs... Sep 24 2014
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results Sep 23 2014
Why investors prefer dividends in a low interest rate environment Sep 23 2014
Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Lower Sep 23 2014
Kinvey Announces Series B--The MBaaS Battle Continues Sep 23 2014
[video] The Personal Story Behind WSJ’s ‘Deadly Medicine’ Sep 22 2014
Today's Market Thorns, Roses, and All Time Highs... Sep 19 2014
Gilead's Zydelig Approved In EU; Imbruvica In Wings Sep 19 2014
Today's Market Thorns, Roses and All Time Highs... Sep 18 2014
Corporate bond ratings do not discern risk Sep 18 2014
AstraZeneca and Eli Lilly to unite for Alzheimer's drug challenge Sep 16 2014
The Keys In This Market: Income & Growth Sep 16 2014
Lawyer grills DePuy executive over safety studies for Pinnacle hips Sep 15 2014
3 Companies Investing In Stem Cell Research Sep 14 2014
Adapting Listerine to a Global Market Sep 12 2014
Addressing Disengagement And Depression Lifts Workers Sep 12 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Gurufocus
ReplyGurufocus - 11 months ago
test


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK